1. Home
  2. AIFU vs ABP Comparison

AIFU vs ABP Comparison

Compare AIFU & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIFU
  • ABP
  • Stock Information
  • Founded
  • AIFU 1998
  • ABP 2004
  • Country
  • AIFU China
  • ABP United States
  • Employees
  • AIFU N/A
  • ABP N/A
  • Industry
  • AIFU
  • ABP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIFU
  • ABP Health Care
  • Exchange
  • AIFU NYSE
  • ABP Nasdaq
  • Market Cap
  • AIFU 69.2M
  • ABP 78.8M
  • IPO Year
  • AIFU 2007
  • ABP N/A
  • Fundamental
  • Price
  • AIFU $1.08
  • ABP $2.07
  • Analyst Decision
  • AIFU
  • ABP
  • Analyst Count
  • AIFU 0
  • ABP 0
  • Target Price
  • AIFU N/A
  • ABP N/A
  • AVG Volume (30 Days)
  • AIFU 158.2K
  • ABP 1.8M
  • Earning Date
  • AIFU 12-27-2024
  • ABP 02-18-2025
  • Dividend Yield
  • AIFU N/A
  • ABP N/A
  • EPS Growth
  • AIFU N/A
  • ABP N/A
  • EPS
  • AIFU 0.38
  • ABP N/A
  • Revenue
  • AIFU $324,923,970.00
  • ABP $122,000.00
  • Revenue This Year
  • AIFU N/A
  • ABP N/A
  • Revenue Next Year
  • AIFU N/A
  • ABP N/A
  • P/E Ratio
  • AIFU $2.83
  • ABP N/A
  • Revenue Growth
  • AIFU N/A
  • ABP N/A
  • 52 Week Low
  • AIFU $1.04
  • ABP $0.95
  • 52 Week High
  • AIFU $6.78
  • ABP $13.00
  • Technical
  • Relative Strength Index (RSI)
  • AIFU N/A
  • ABP N/A
  • Support Level
  • AIFU N/A
  • ABP N/A
  • Resistance Level
  • AIFU N/A
  • ABP N/A
  • Average True Range (ATR)
  • AIFU 0.00
  • ABP 0.00
  • MACD
  • AIFU 0.00
  • ABP 0.00
  • Stochastic Oscillator
  • AIFU 0.00
  • ABP 0.00

About AIFU FANHUA INC SPON ADS EACH REPR 20 ORD SHS

AIX Inc is a technology-driven financial services provider company in China. It is an intelligent platform that creates a supportive and collaborative environment and provides solutions that integrate technology, products, services, operations, capital, and professional support for individual agents and sales organizations. The group uses technology, AI, and data-driven insights, pioneering the financial services that are delivered, its transformation, and empowering industry development. It connects customers with financial institutions, investment opportunities, and service providers, offering insurance, wealth management, and other value-added services.

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

Share on Social Networks: